HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Avon to invest $200 mil. in global advertising by 2000, execs tell investors.

This article was originally published in The Rose Sheet

Executive Summary

AVON DOUBLING GLOBAL AD SPEND TO $200 MIL. BY 2000, bringing the company's ad investment to 3% of sales versus the 1.4% of sales the direct marketer spends on advertising now, Avon CEO Jim Preston told investors at a meeting in New York City Oct. 23. Calling Avon's direct-selling program the "best in the world," Preston said the company will fulfill its "real potential" by using the larger budget to "raise consumer awareness" and increase access to products. Money for the ad spend will come from a number of cost-cutting and investment initiatives Avon is undertaking over the next two years.

Latest Headlines
See All
UsernamePublicRestriction

Register

RS004790

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel